These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9769363)

  • 1. A set of six Gene expression biomarkers and their thresholds identify rat liver tumorigens in short-term assays.
    Lewis RW; Hill T; Corton JC
    Toxicology; 2020 Oct; 443():152547. PubMed ID: 32755643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the capacity of nongenotoxic carcinogens to induce oxidative stress is subject to marked variability.
    Henderson CJ; Cameron AR; Chatham L; Stanley LA; Wolf CR
    Toxicol Sci; 2015 May; 145(1):138-48. PubMed ID: 25690736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated and non-differentiated HepaRG™ cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens.
    Gutmann M; Stimpfl E; Langmann G; Koudelka H; Mir-Karner B; Grasl-Kraupp B
    Toxicol Lett; 2023 Dec; 390():15-24. PubMed ID: 37890683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A toxicogenomic approach for the risk assessment of the food contaminant acetamide.
    Nault R; Bals B; Teymouri F; Black MB; Andersen ME; McMullen PD; Krishnan S; Kuravadi N; Paul N; Kumar S; Kannan K; Jayachandra KC; Alagappan L; Patel BD; Bogen KT; Gollapudi BB; Klaunig JE; Zacharewski TR; Bringi V
    Toxicol Appl Pharmacol; 2020 Feb; 388():114872. PubMed ID: 31881176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case examples of an evaluation of the human relevance of the pyrethroids/pyrethrins-induced liver tumours in rodents based on the mode of action.
    Yamada T
    Toxicol Res (Camb); 2018 Jul; 7(4):681-696. PubMed ID: 30090614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of genetic instability and tumour formation: a review and hypothesis of a nongenotoxic mechanism.
    Bignold LP
    Cell Mol Life Sci; 2003 Jun; 60(6):1107-17. PubMed ID: 12861379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational Relevance of Rodent Models to Predict Human Liver Disease.
    Mahapatra D; Maronpot R
    Toxicol Pathol; 2023 Oct; 51(7-8):482-486. PubMed ID: 38494947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-term Assays.
    Corton JC; Hill T; Sutherland JJ; Stevens JL; Rooney J
    Toxicol Sci; 2020 Sep; 177(1):11-26. PubMed ID: 32603430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment.
    Corton JC; Ledbetter V; Cohen SM; Atlas E; Yauk CL; Liu J
    Toxicol Sci; 2024 Oct; 201(2):174-189. PubMed ID: 39137154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humans.
    Yoshizato K; Tateno C
    PPAR Res; 2009; 2009():476217. PubMed ID: 19884982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cell nuclear damage probably induces chronic refractory diseases].
    Li MJ; Li J; Niu DS
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Aug; 41(8):636-640. PubMed ID: 37667165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology and Biodegradability of a Phthalate-Free and Bio-Based Novel Plasticizer.
    Simar-Mentières S; Nesslany F; Sola ML; Mortier S; Raimbault JM; Gondelle F; Chabot L; Pandard P; Wils D; Chentouf A
    J Toxicol; 2021; 2021():9970896. PubMed ID: 34335742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of epigenetic effects of citrinin using a yeast-based bioassay.
    Sugiyama KI; Furusawa H; Honma M
    Mycotoxin Res; 2019 Nov; 35(4):363-368. PubMed ID: 31077037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor α (PPARα) mRNA expression in human hepatocellular carcinoma tissue and non-cancerous liver tissue.
    Kurokawa T; Shimomura Y; Bajotto G; Kotake K; Arikawa T; Ito N; Yasuda A; Nagata H; Nonami T; Masuko K
    World J Surg Oncol; 2011 Dec; 9():167. PubMed ID: 22168458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.
    Grau R; Díaz-Muñoz MD; Cacheiro-Llaguno C; Fresno M; Iñiguez MA
    PPAR Res; 2008; 2008():352437. PubMed ID: 18670614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.
    Boitier E; Gautier JC; Roberts R
    Comp Hepatol; 2003 Jan; 2(1):3. PubMed ID: 12622871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
    Chevalier S; Roberts RA
    Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
    Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
    Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.